2017
October 2017
Strategic Priority IV aims to promote collaboration in prevention research across the NIH and with government and private partners. The goal is to identify and share best practices and models in collaboration, build support infrastructure, and coordinate funding opportunities.
July 2017
The goal of Strategic Priority III is to promote the best available methods in prevention research. Over the past year, the ODP has continued to work toward improving the quality of prevention research methods by updating and expanding its prevention science tools and training opportunities.
May 2017
Identifying research gaps can lead to new research that ultimately improves the public health. With Strategic Priority II, the ODP identifies prevention research areas for investment or further expansion by the NIH.
March 2017
The Office of Disease Prevention’s (ODP) Strategic Priority I focuses on the development of new tools to characterize the National Institutes of Health (NIH) prevention research portfolio.
2016
December 2016
The mid-course of the ODP Strategic Plan for Fiscal Years 2014–2018 offers the opportunity to highlight accomplishments for the six priority areas in 2016 and provide an update on the Tobacco Regulatory Science Program (TRSP).
October 2016
The ODP is leveraging its website and other digital communication tools to increase the visibility of and foster work on prevention research at the NIH and across the country.
August 2016
The ODP has collaborated with multiple partners to fund research and training opportunities, initiate first steps in a trans-NIH dissemination and implementation (D&I) portfolio analysis, and provide information and tools to support investigators, public health professionals, and other stakeholders.
June 2016
On May 5, 2016, the FDA issued its final deeming rule to extend its authorities to all categories of products that meet the statutory definition of "tobacco product" in the Federal Food, Drug, and Cosmetic Act, except accessories of such newly deemed tobacco products.
April 2016
Strategic Priority IV aims to encourage collaboration among NIH Institutes and Centers (ICs) and their government and private partners engaged in prevention research to identify and share best collaborative practices and models, build support infrastructure, and coordinate funding opportunities.
February 2016
To enhance the quality of prevention research at the NIH, the ODP is working to promote the use of the best available methods in prevention research and support the development of prevention science tools.
January 2016
As the ODP enters the third year of its Strategic Plan, progress has been made with the six strategic priorities and the Tobacco Regulatory Science Program (TRSP).
2015
October 2015
Despite overall progress in reducing tobacco consumption, tobacco remains the leading cause of preventable disease and death in the United States. There is growing concern about the potential public health impact of new tobacco products, such as electronic cigarettes (e-cigarettes)—particularly among youth.
August 2015
Identifying research gaps can lead to increased efforts and new research that ultimately improve public health. To achieve this aim, the Office of Disease Prevention (ODP) is identifying prevention research areas for investment or expanded effort by the NIH.
June 2015
Preventable health risks, such as smoking, obesity, and physical inactivity, cause up to half of all deaths in the United States. To reduce these risks and the associated burden of disease, the NIH spends approximately 20% of its annual budget on prevention research.
2014
August 2014
As we enter the new fiscal year, I am pleased to report on the progress we have made related to the Office of Disease Prevention's (ODP) first Strategic Plan. This plan, which was approved by the NIH Director in January 2014, includes six strategic priorities that will guide the work of our office through 2018.
February 2014
As we enter 2014, I am pleased to announce the completion of the Office of Disease Prevention's (ODP) first strategic plan. After a year of hard work, this plan was approved by the National Institutes of Health (NIH) Director on January 2, 2014. We identified six strategic priorities, highlighted below, that will guide the work of the Office during 2014-2018:
2013
August 2013
When I came to the Office of Disease Prevention (ODP) in October 2012, I was excited at the prospect of leading a new strategic planning effort, developing new programs, strengthening partnerships within the National Institutes of Health (NIH) and with other federal agencies, and expanding our dissemination efforts. I am pleased to report our progress to date, with much more to come in the future.
